JNK/c-Jun

More Information »JNKs (c-Jun N-terminal kinases) are a group of mitogen-activated protein kinases (MAPKs), originally called stress activated protein kinases (SAPKs), because they are activated by various environmental stresses. They can also be activated by cytokines and growth factors.

JNK/c-Jun Products

Inhibitors
Cat.No.	Product Name / Activity
2651	AEG 3482
	Inhibitor of JNK signaling
3314	BI 78D3
	Selective, competitive JNK inhibitor
1989	c-JUN peptide
	Peptide inhibitor of JNK/c-Jun interaction
1565	JIP-1 (153-163)
	JNK-selective inhibitor peptide
1496	SP 600125
	Novel and selective JNK inhibitor
3607	SU 3327
	Selective JNK inhibitor
2827	TCS JNK 5a
	Selective inhibitor of JNK2 and JNK3
3222	TCS JNK 6o
	Selective JNK inhibitor
Activators
Cat.No.	Product Name / Activity
1290	Anisomycin
	Activates JNK/SAPK/p38 MAP kinase

Related Categories

MAPK Signaling p38 MAPK

ERK Cytokine and NF-κB Signaling

Quick Order

Find multiple products by catalog number

Cancer Research Guide

Request your free copy

Highlights over 350 products for cancer research. Request a copy or view PDF today.

Kinases Product Listing

Highlights over 350 products for kinase research. Request a copy or view PDF today.

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Some of the most potent
kinase inhibitors all on one plate

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

Immunology Guide

Highlights over 150 products for immunology research. Request a copy or view PDF today.

MAPK Signaling Review

Written by Elma Zaganjor and Melanie H. Cobb, leading experts. Request a copy or view PDF today.

Calcium Imbalance and Neuroprotective Targets

Written by E. Besancon et al

'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.